MRI and Active Surveillance for Prostate Cancer

MRI and Active Surveillance for Prostate Cancer

Since the introduction of Prostate-Specific Antigen (PSA) screening, prostate cancer mortality has decreased [...]

Bibliographic Details
Main Authors:	Angelo Porreca, Michele Colicchia, Gian Maria Busetto, Matteo Ferro
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Diagnostics
Subjects:	active surveillance ·prostate cancer MRI imaging
Online Access:	https://www.mdpi.com/2075-4418/10/8/590

Similar Items

Multiparametric MRI and targeted biopsies in the management of prostate cancer patients on active surveillance
by: Kiri eSandler, et al.
Published: (2015-01-01)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
by: Matteo Ferro, et al.
Published: (2017-05-01)

MRI/US fusion prostate biopsy in men on active surveillance: Our experience
by: Vito Lacetera, et al.
Published: (2021-03-01)

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
by: Pietro Pepe, et al.
Published: (2016-12-01)

Utilization of Multiparametric MRI of Prostate in Patients under Consideration for or Already in Active Surveillance: Correlation with Imaging Guided Target Biopsy
by: Jinxing Yu, et al.
Published: (2020-06-01)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
by: Salonee Shah, et al.
Published: (2021-05-01)

MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer
by: Suraj Samtani, et al.
Published: (2021-08-01)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
by: Subhabrata Mukherjee, et al.
Published: (2021-02-01)

Evaluation of various active surveillance protocols in prostate cancer
by: Kayhan Yılmaz, et al.
Published: (2014-06-01)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
by: Arnas Rakauskas, et al.
Published: (2021-07-01)

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
by: Ravi Kacker, et al.
Published: (2016-01-01)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
by: Julie Y. An, et al.
Published: (2017-10-01)

Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?
by: Marco Roscigno, et al.
Published: (2020-12-01)

Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate
by: Hagmann, S., et al.
Published: (2022)

The importance of PSA-Density in active surveillance for prostate cancer
by: Caner Ediz, et al.
Published: (2020-06-01)

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance
by: Roberta Mazzucchelli, et al.
Published: (2014-12-01)

Multiparametric-MRI in diagnosis of prostate cancer
by: Sangeet Ghai, et al.
Published: (2015-01-01)

Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance
by: Nuno Ramos, et al.
Published: (2020-12-01)

Psychosocial Correlates of Psychological Distress and Arousal in Prostate Cancer Survivors Undergoing Active Surveillance
by: Bustillo, Natalie Escobio
Published: (2011)

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
by: Belén Pastor-Navarro, et al.
Published: (2021-06-01)

Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer—A population‐based cohort study
by: Rano Matta, et al.
Published: (2020-10-01)

Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance
by: Zachary A. Glaser, et al.
Published: (2017-10-01)

Active surveillance for prostate cancer: to whom, when and how
by: M. S. Taratkin, et al.
Published: (2019-09-01)

The accuracy of prostate biopsy to assign patients with low-grade prostate cancer to active surveillance
by: Ghleilib, Intisar Ali
Published: (2016)

Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?
by: Soroush Rais-Bahrami, et al.
Published: (2017-01-01)

Analysis of different tumor volume thresholds of insignificant prostate cancer and their implications for active surveillance patient selection and monitoring
by: Dong Hoon Lee
Published: (2014-06-01)

Assessment of PSIM (Prostatic Systemic InflammatoryMarkers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk ProstateCancer Who Met the Inclusion Criteria for Active Surveillance
by: Matteo Ferro, et al.
Published: (2021-02-01)

Will multiparametric magnetic resonance imaging be the future tool to detect clinically significant prostate cancer?
by: Gianluca eGiannarini, et al.
Published: (2014-11-01)

Prostate volume effect on Gleason score upgrading in active surveillance appropriate patients
by: Emre Çamur, et al.
Published: (2019-07-01)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
by: Sangeet Ghai, et al.
Published: (2015-01-01)

Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance
by: Zambrano Norman, et al.
Published: (2014-04-01)

Watchful Waiting Active Surveillance in Prostate Cancer Patients – a Population-Based Study Using the SEER-Medicare Linked Database
by: Kou, Tzuyung Doug
Published: (2008)

Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients
by: Ali-Reza Sharif-Afshar, et al.
Published: (2016-05-01)

A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
by: Samuel W. D. Merriel, et al.
Published: (2021-02-01)

Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review
by: Cécile Manceau, et al.
Published: (2021-08-01)

MRI-derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens
by: Michael Andre Liss, et al.
Published: (2015-02-01)

Computer Extracted Features from Initial H&E Tissue Biopsies Predict Disease Progression for Prostate Cancer Patients on Active Surveillance
by: Sacheth Chandramouli, et al.
Published: (2020-09-01)

Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
by: Rasmus Nilsson, et al.
Published: (2021-03-01)